Investigational drugs for autonomic dysfunction in Parkinson's disease

Autores
Pérez Lloret, Santiago
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Autonomic disturbances are common symptoms of Parkinson’s disease (PD),[1,2] with orthostatic hypotension affecting 20%–65% of patients,[3,4] sialorrhea about 75%,[5,6] sexual dysfunction 60% of men, urinary dysfunction up to 40%, and gastrointestinal motility disorders causing constipation up to 80%.[2] These symptoms can impair patients’ quality of life, worsen the burden of their caregivers, cause hospitalization and institutionalization, and increase the cost of care of patients with PD by four times.
Fil: Pérez Lloret, Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina
Materia
Enfermedad de Parkinson
Trastornos Autonómicos
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/39000
Acceder
id CONICETDig_62855cc086c405f6692825ca4af471b5
oai_identifier_str oai:ri.conicet.gov.ar:11336/39000
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Investigational drugs for autonomic dysfunction in Parkinson's diseasePérez Lloret, SantiagoEnfermedad de ParkinsonTrastornos Autonómicoshttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Autonomic disturbances are common symptoms of Parkinson’s disease (PD),[1,2] with orthostatic hypotension affecting 20%–65% of patients,[3,4] sialorrhea about 75%,[5,6] sexual dysfunction 60% of men, urinary dysfunction up to 40%, and gastrointestinal motility disorders causing constipation up to 80%.[2] These symptoms can impair patients’ quality of life, worsen the burden of their caregivers, cause hospitalization and institutionalization, and increase the cost of care of patients with PD by four times.Fil: Pérez Lloret, Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; ArgentinaInforma Healthcare2016-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/39000Pérez Lloret, Santiago; Investigational drugs for autonomic dysfunction in Parkinson's disease; Informa Healthcare; Expert Opinion On Investigational Drugs; 25; 3; 3-2016; 259-2621354-3784CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1517/13543784.2016.1135128info:eu-repo/semantics/altIdentifier/doi/10.1517/13543784.2016.1135128info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:11:48Zoai:ri.conicet.gov.ar:11336/39000instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:11:49.161CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Investigational drugs for autonomic dysfunction in Parkinson's disease
title Investigational drugs for autonomic dysfunction in Parkinson's disease
spellingShingle Investigational drugs for autonomic dysfunction in Parkinson's disease
Pérez Lloret, Santiago
Enfermedad de Parkinson
Trastornos Autonómicos
title_short Investigational drugs for autonomic dysfunction in Parkinson's disease
title_full Investigational drugs for autonomic dysfunction in Parkinson's disease
title_fullStr Investigational drugs for autonomic dysfunction in Parkinson's disease
title_full_unstemmed Investigational drugs for autonomic dysfunction in Parkinson's disease
title_sort Investigational drugs for autonomic dysfunction in Parkinson's disease
dc.creator.none.fl_str_mv Pérez Lloret, Santiago
author Pérez Lloret, Santiago
author_facet Pérez Lloret, Santiago
author_role author
dc.subject.none.fl_str_mv Enfermedad de Parkinson
Trastornos Autonómicos
topic Enfermedad de Parkinson
Trastornos Autonómicos
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Autonomic disturbances are common symptoms of Parkinson’s disease (PD),[1,2] with orthostatic hypotension affecting 20%–65% of patients,[3,4] sialorrhea about 75%,[5,6] sexual dysfunction 60% of men, urinary dysfunction up to 40%, and gastrointestinal motility disorders causing constipation up to 80%.[2] These symptoms can impair patients’ quality of life, worsen the burden of their caregivers, cause hospitalization and institutionalization, and increase the cost of care of patients with PD by four times.
Fil: Pérez Lloret, Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina
description Autonomic disturbances are common symptoms of Parkinson’s disease (PD),[1,2] with orthostatic hypotension affecting 20%–65% of patients,[3,4] sialorrhea about 75%,[5,6] sexual dysfunction 60% of men, urinary dysfunction up to 40%, and gastrointestinal motility disorders causing constipation up to 80%.[2] These symptoms can impair patients’ quality of life, worsen the burden of their caregivers, cause hospitalization and institutionalization, and increase the cost of care of patients with PD by four times.
publishDate 2016
dc.date.none.fl_str_mv 2016-03
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/39000
Pérez Lloret, Santiago; Investigational drugs for autonomic dysfunction in Parkinson's disease; Informa Healthcare; Expert Opinion On Investigational Drugs; 25; 3; 3-2016; 259-262
1354-3784
CONICET Digital
CONICET
url http://hdl.handle.net/11336/39000
identifier_str_mv Pérez Lloret, Santiago; Investigational drugs for autonomic dysfunction in Parkinson's disease; Informa Healthcare; Expert Opinion On Investigational Drugs; 25; 3; 3-2016; 259-262
1354-3784
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1517/13543784.2016.1135128
info:eu-repo/semantics/altIdentifier/doi/10.1517/13543784.2016.1135128
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Informa Healthcare
publisher.none.fl_str_mv Informa Healthcare
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842270171607072768
score 13.13397

Publicaciones similares